德国海德堡&美国马萨诸塞州剑桥–(BUSINESS WIRE)–(美国商业资讯)– Novaliq是一家生物制药公司,专注于基于其独有的无水EyeSol®药物技术体系,开发同类首创及同类最优的眼科治疗方案。公司今日宣布,美国食品药品监督管理局(FDA)已完成对其NOV05研究性新药(IND)申请的审评并予以放行。这是Novaliq首个用于治疗内眼疾病的IND申请。 NOV05是一款基于EyeSol®递送体系的他克莫司眼用溶液,属于创新性的无类固醇外用抗炎治疗方案。本次IND获FDA放行,使公司…
GenSight Biologics annonce les résultats de son Assemblée Générale Extraordinaire du 28 janvier 2026
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le traitement des m…
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Eye care practitioners urge FDA to approve low-dose atropine
A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the progression of pediatric myopia.It comes after the FDA decided not to approve SYD-101 (0.01% atropine, Sydnexis) in October despite ackno…
IL-6 inhibition promising as pathway for retinal disease therapy
WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the treatment of exudative retinal diseases.Rahimy said that even with the success of anti-VEGF therapies, many patie…
Set boundaries, expectations to prevent ‘mentorship malpractice’
LAS VEGAS — Effective mentorship can accelerate careers, but toxic mentoring behaviors can just as easily derail academic progress if left unchecked, Frank I. Scott, MD, MSCE, warned attendees at Crohn’s & Colitis Congress.“We know that mentorship can …